1. Home
  2. HTLD vs SPTX Comparison

HTLD vs SPTX Comparison

Compare HTLD & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartland Express Inc.

HTLD

Heartland Express Inc.

HOLD

Current Price

$11.87

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$22.29

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HTLD
SPTX
Founded
1978
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
HTLD
SPTX
Price
$11.87
$22.29
Analyst Decision
Hold
Analyst Count
6
0
Target Price
$11.50
N/A
AVG Volume (30 Days)
605.7K
124.9K
Earning Date
04-23-2026
N/A
Dividend Yield
0.60%
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$805,709,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.36
N/A
P/E Ratio
$170.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.00
$17.59
52 Week High
$16.64
$28.38

Technical Indicators

Market Signals
Indicator
HTLD
SPTX
Relative Strength Index (RSI) 39.50 43.19
Support Level $11.75 $18.72
Resistance Level $12.13 $22.75
Average True Range (ATR) 0.41 2.06
MACD 0.01 -0.40
Stochastic Oscillator 21.13 9.60

Price Performance

Historical Comparison
HTLD
SPTX

About HTLD Heartland Express Inc.

Heartland Express Inc, along with its subsidiaries, operates as a short, medium, and long-haul truckload carrier and transportation services provider. It mainly provides nationwide asset-based dry van truckload service for shippers across the United States, along with cross-border freight and other transportation services offered through third-party partnerships in Mexico. The group operates under the brand names of Heartland Express, Millis Transfer, Smith Transport, and CFI (for services within Mexico).

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: